Cite
HARVARD Citation
Zhong, L. et al. (2021). Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer. Basic & clinical pharmacology & toxicology. 128 (1), pp. 169-182. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhong, L. et al. (2021). Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer. Basic & clinical pharmacology & toxicology. 128 (1), pp. 169-182. [Online].